These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 9541938)

  • 1. [Morphogenesis of benign prostatic hyperplasia and prostatic carcinoma].
    Bonkhoff H; Remberger K
    Pathologe; 1998 Jan; 19(1):12-20. PubMed ID: 9541938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model.
    Bonkhoff H; Remberger K
    Prostate; 1996 Feb; 28(2):98-106. PubMed ID: 8604398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell features of benign and malignant prostate epithelial cells.
    De Marzo AM; Nelson WG; Meeker AK; Coffey DS
    J Urol; 1998 Dec; 160(6 Pt 2):2381-92. PubMed ID: 9817389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A theoretical rationale on the histogenesis of premalignant lesions and early carcinoma of the prostate.
    Botticelli AR
    Pathologica; 1994 Apr; 86(2):128-41. PubMed ID: 7524011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the basal cells in premalignant changes of the human prostate: a stem cell concept for the development of prostate cancer.
    Bonkhoff H
    Eur Urol; 1996; 30(2):201-5. PubMed ID: 8875201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New aspects in histogenesis of hyperplasia and cancers of the prostate].
    Bonkhoff H; Remberger K
    Verh Dtsch Ges Pathol; 1993; 77():31-9. PubMed ID: 7511302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there a relationship between benign prostatic hyperplasia and prostatic cancer?
    Pagano F; Zattoni F; Vianello F; Piazza R; Capitanio G
    Eur Urol; 1991; 20 Suppl 1():31-5. PubMed ID: 1722159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphogenetic concepts of normal and abnormal growth in the human prostate.
    Bonkhoff H; Remberger K
    Virchows Arch; 1998 Sep; 433(3):195-202. PubMed ID: 9769121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of prostatic carcinoma: the pathologist's perspective.
    Algaba F; Trias I; Arce Y
    Recent Results Cancer Res; 2007; 175():9-24. PubMed ID: 17432551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant transformation of human prostatic epithelium is associated with the loss of androgen receptor immunoreactivity in the surrounding stroma.
    Olapade-Olaopa EO; MacKay EH; Taub NA; Sandhu DP; Terry TR; Habib FK
    Clin Cancer Res; 1999 Mar; 5(3):569-76. PubMed ID: 10100708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prostate gland-transition zone lesions. Etiology, growth regulation, growth factors, genetic changes].
    Pavelić J; Zeljko Z
    Lijec Vjesn; 2002; 124(6-7):211-9. PubMed ID: 19658339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells.
    De Marzo AM; Meeker AK; Epstein JI; Coffey DS
    Am J Pathol; 1998 Sep; 153(3):911-9. PubMed ID: 9736039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paneth cell-like change of the prostate gland. A histological, immunohistochemical, and electron microscopic study.
    Weaver MG; Abdul-Karim FW; Srigley J; Bostwick DG; Ro JY; Ayala AG
    Am J Surg Pathol; 1992 Jan; 16(1):62-8. PubMed ID: 1370193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuroendocrine differentiation in prostate cancer. An unrecognized and therapy-resistant phenotype].
    Bonkhoff H; Fixemer T
    Urologe A; 2004 Jul; 43(7):836-42. PubMed ID: 15048555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell kinetics of prostate exocrine and neuroendocrine epithelium and their differential interrelationship: new perspectives.
    Xue Y; Smedts F; Verhofstad A; Debruyne F; de la Rosette J; Schalken J
    Prostate Suppl; 1998; 8():62-73. PubMed ID: 9690665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The link between benign prostatic hyperplasia and prostate cancer.
    Ørsted DD; Bojesen SE
    Nat Rev Urol; 2013 Jan; 10(1):49-54. PubMed ID: 23165396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells.
    Gao J; Arnold JT; Isaacs JT
    Cancer Res; 2001 Jul; 61(13):5038-44. PubMed ID: 11431338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine cells in benign and malignant prostate tissue: morphogenesis, proliferation, and androgen receptor status.
    Bonkhoff H
    Prostate Suppl; 1998; 8():18-22. PubMed ID: 9690659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.